Question · asked by 1 review
CR oxycodone vs CR morphine: Participant preference
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
CR oxycodone vs CR morphine Participant preference (end of treatment in a cross‐over trial with each phase lasting seven days) · adults with cancer‐related pain Oxycodone for cancer‐related pain (2022) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 23 participants | Very low |
CR oxycodone vs CR morphine Participant preference · adults with cancer‐related pain Oxycodone for cancer‐related pain (2017) · Cochrane Headline outcomes onlyearlier version CD003870.PUB6, superseded | no estimate extracted | 1 study · 23 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Oxycodone for cancer‐related pain 2022 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.